Errors of antithrombotic therapy in management of pregnancy and childbirth after in vitro fertilization and transfer of two embryos

Thrombophilia might be the essential pathogenetic mechanism of thromboembolism associated with pregnancy. Venous thromboembolism during or after assisted reproductive technologies is predicted to emerge due to increased number of women undergoing this technique. Low molecular weight heparins was effective for preventing recurrent thromboembolism and severe obstetric complications. Women with personal or family history of thromboembolism or with history of obstetric complications should be screened for thrombophilia.

1. Liatsikos S. A., Tsikouras P., Manav B. et al. Inherited thrombophilia and reproductive disorders. J Turk Ger Gynecol Assoc. 2016;17(1):45–50. https://doi.org/10.5152/jtgga.2016.15212.

2. Makatsariya N. A., Khizroeva D. Kh., Bitsadze V. O. et al. Antiphospholipid antibodies in patients with IVF failures. [Antifosfolipidnye antitela u pacientok s neudachami EKO]. Akusherstvo, Ginekologia i Reprodukcia. 2014;8(4):93. (In Russ.).

3. High risk pregnancy. Eds. A. D. Makatsariya, F. A. Chervenak, V. O. Bitsadze. [Beremennost’ vysokogo riska. Rukovodstvo dlya vrachej. Pod. red. A. D. Makacariya, F. A. Chervenak, V. O. Bicadze]. Moskva: MIA, 2015. 920 s. (In Russ.).

4. Akinshina S. V., Makatsariya N. A., Bitsadze V. O. et al. Thrombophilia and thromboembolic complications associated with use of assisted reproductive technologies. [Trombofiliya i tromboembolicheskie oslozhneniya, svyazannye s ispol’zovaniem vspomogatel’nyh reproduktivnyh tekhnologij]. Akusherstvo, Ginekologia i Reprodukcia. 2014;8(2):89–96. (In Russ.).

5. Khizroeva D. Kh., Mikhaylidi I., Stuleva N. S. Significance of protein C determination in obstetric practice. [Znachenie opredeleniya proteina S v akusherskoj praktike]. Prakticheskaya medicina. 2013;(7):52–7. (In Russ.).

6. Stuleva N. S., Khizroeva D. Kh., Mashkova T. Ya., Abramyan G. R. Circulation of antiphospholipid antibodies and IVF failures. [Cirkulyaciya antifosfolipidnyh antitel i neudachi EKO]. Akusherstvo, Ginekologia i Reprodukcia. 2015;9(3):6–10. (In Russ.). https://doi.org/10.17749/2070-4968.2015.9.3.006-010.

7. Peters K., Gordon N., Ricciotti N. et al. Hemostatic effects of two desogestrel-containing combined oral contraceptive regimens: a multinational, multicenter, randomized, open-label study. Clin Exp Obstet Gynecol. 2016;43(3):334–40.

8. Akinshina S., Makatsariya A., Bitsadze V. et al. Thromboprophylaxis in pregnant women with thrombophilia and a history of thrombosis. J Perinat Med. 2018;46(8):893–9. https://doi.org/10.1515/jpm-2017-0329.

9. Grandone E., Di Micco P. P., Villani М. et al. Venous thromboembolism in women undergoing assisted reproductive technologies: data from the RIETE Registry. Thromb Haemost. 2018;118(11):1962–8. https://doi.org/10.1055/s-0038-1673402.

10. Qublan H. S., Eid S. S., Ababneh H. A. et al. Acquired and inherited thrombophilia: implication in reccurent IVF and embryo transfer failure. Hum Reprod. 2006;21(10):2694–8. https://doi.org/10.1093/humrep/del203.